Levine and McPhee Participate in Food and Drug Law Institute Conference in China
Levine spoke on a panel titled “From Raw Materials to Finished Drug Products: Quality and Access are Key to Economic Success,” discussing challenges and successes in the assurance of high-quality active pharmaceutical ingredients and finished drug products. McPhee spoke on a panel titled “Crossing the Rubicon: When Regulatory Concerns Become Enforcement Actions,” exploring when issues go from being regulatory concerns to government enforcement actions against life-sciences companies doing business in multiple jurisdictions, particularly the United States and China.
The conference, held in partnership with Tsinghua University School of Law and Health Law Research Center, addressed food and drug law, regulation and policy in China and the United States. Top government officials and international experts discussed the current legal, regulatory and economic environment for the development of food, cosmetics, dietary supplements, pharmaceuticals and medical devices in both countries.